Skip to main content

Table 3 Multivariate Cox regression analysis

From: Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group

Disease-free survival

HR

95% CI

p value

Number of positive nodes

 ≥4 versus 1–3

2.51

1.88–3.63

<0.001

Tumor size

 2–5 cm versus ≤2 cm

1.45

1.08–1.95

0.013

 >5 cm versus ≤2 cm

1.65

1.10–2.48

0.015

Adjuvant HT

 Yes versus no

0.69

0.51–0.93

0.016

OPN mRNA expression

 High versus low

1.34

1.04–1.71

0.022

Overall survival

Number of positive nodes

 ≥4 versus 1–3

3.59

2.48–5.19

<0.001

Tumor size

 2–5 cm versus ≤2 cm

1.59

1.13–2.34

0.009

 >5 cm versus ≤2 cm

1.87

1.18–2.97

0.008

Adjuvant HT

 Yes versus no

0.55

0.39–0.76

<0.001

OPN mRNA expression

 High versus low

1.54

1.16–2.05

0.003

  1. HR hazard ratio, CI confidence interval